
Image: Aditya Irawan/NurPhoto via AP Images
Cancer clinical trials (CCTs) provide patients an opportunity to receive experimental drugs, tests, and/or procedures that can lead to remissions. For some, a CCT may seem like their only option. Yet little is known about the experiences of patient participants who withdraw from CCTs.
Now, a first-of-its-kind study from the University of Pennsylvania School of Nursing (Penn Nursing) helps to clarify the post-trial needs of these patients and define what constitutes responsible transitions when patients exit CCTs.
“Understanding the post-trial needs of patients with cancer and their families represents a measure of ethical respect of the many contributions that patients with cancer make to advancing our scientific knowledge and finding treatments that save lives,” says Connie M. Ulrich, the Lillian S. Brunner Chair in Medical and Surgical Nursing, professor of nursing, professor of medical ethics and health policy, and lead investigator.
The study, “Experiences of Patients After Withdrawal from Cancer Clinical Trials,” is set for publication on the JAMA Network.
The study highlights three important points:
Read more at Penn Nursing News.
From Penn Nursing News
Image: Aditya Irawan/NurPhoto via AP Images
nocred
Image: Michael Levine
A West Philadelphia High School student practices the drum as part of a July summer program in partnership with the Netter Center for Community Partnerships and nonprofit Musicopia.
nocred